Biochemistry & Molecular Biology Letters
ISSN (PRINT): 2454-9304

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Prostate-specific Antigen Journals

 Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood. The blood level of PSA is often elevated in men with prostate cancer, and the PSA test was originally approved by the FDA in 1986 to monitor the progression of prostate cancer in men who had already been diagnosed with the disease. In 1994, the FDA approved the use of the PSA test in conjunction with a digital rectal exam (DRE) to test asymptomatic men for prostate cancer. Men who report prostate symptoms often undergo PSA testing (along with a DRE) to help doctors determine the nature of the problem. In addition to prostate cancer, a number of benign (not cancerous) conditions can cause a man’s PSA level to rise.   

High Impact List of Articles

Relevant Topics in Biochemistry

Awards Nomination

Table of Contents

Google Scholar citation report
Citations : 18

Biochemistry & Molecular Biology Letters received 18 citations as per Google Scholar report

Citation image

Indexed In

  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • ICMJE

View More

For Authors

For Librarians

Flyer

Open Access Journals